This page lists the scientific publications related to the EVAg project. The default filter is set to "publications for which the research was funded by the EVAg project". You can change this filter to another value by picking a different filter from the drop-down list and clicking on the "Apply" button.

346 publications displayed

Date Namesort descending Journal EVAg
Mar 2020 Rabies in the African Civet: An Incidental Host for Lyssaviruses? Viruses Research funded by EVAg, Published by EVAg partner
Jan 2022 Rapid and direct quantification of the SARS-CoV-2 virus with an ultrasensitive nanobody-based photonic nanosensor Sensors & Diagnostics Research funded by EVAg, Published by EVAg partner
Dec 2020 Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis Nature Communications Research funded by EVAg, Published by EVAg partner
Jun 2021 Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein Water Research Research funded by EVAg, Published by EVAg end-user
Dec 2018 Re-visiting the evolution, dispersal and epidemiology of Zika virus in Asia Emerging Microbes & Infections Research funded by EVAg, Published by EVAg partner
Aug 2021 Real-Life Head-to-Head Comparison of Performance of Two High-Throughput Automated Assays for the Detection of SARS-CoV-2 RNA in Nasopharyngeal Swabs The Journal of Molecular Diagnostics Research funded by EVAg, Published by EVAg partner
Oct 2018 Reassortment events in the evolution of hantaviruses Virus Genes Research funded by EVAg, Published by EVAg partner
Oct 2017 Regulation of NF-κB by the p105-ABIN2-TPL2 complex and RelAp43 during rabies virus infection PLoS Pathogens Research funded by EVAg, Published by EVAg partner
May 2018 Relationship between circulating vascular endothelial growth factor and its soluble receptor in patients with hemorrhagic fever with renal syndrome Emerging Microbes & Infections Research funded by EVAg, Published by EVAg partner
Oct 2020 Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses Antiviral Research Research funded by EVAg, Published by EVAg end-user
Feb 2018 Reply to Baylis et al., “External Quality Assessment (EQA) of Molecular Detection of Zika Virus: Value of the 1st World Health Organization International Standard” Journal of Clinical Microbiology Research funded by EVAg, Published by EVAg partner
Oct 2019 Rescue of Replication-Competent ZIKV Hidden in Placenta-Derived Mesenchymal Cells Long After the Resolution of the Infection Open Forum Infectious Diseases Research funded by EVAg, Published by EVAg partner
Jan 1995 Resistance toTospoviruses inNicotiana benthamianaTransformed with the N Gene of Tomato Spotted Wilt Virus: Correlation Between Transgene Expression and Protection In Primary Transformants Molecular Plant-Microbe Interactions Research funded by EVAg, Published by EVAg end-user
Jul 2018 Role of biobanks in the study of population immunity Journal Infectology Research funded by EVAg, Published by EVAg partner
Apr 2021 Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen Journal of Clinical Medicine Research funded by EVAg, Published by EVAg partner
Dec 2017 Sand fly and Leishmania spp. survey in Vojvodina (Serbia): first detection of Leishmania infantum DNA in sand flies and the first record of Phlebotomus (Transphlebotomus) mascittii Grassi, 1908 Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Mar 2016 Sandfly-Borne Phlebovirus Isolations from Turkey: New Insight into the Sandfly fever Sicilian and Sandfly fever Naples Species PLoS Neglected Tropical Diseases Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Feb 2019 Sandfly-Borne Viruses of Demonstrated/Relevant Medical Importance Vectors and Vector-Borne Zoonotic Diseases Research funded by EVAg, Published by EVAg partner
Apr 2023 SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel Biomedicines Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Dec 2020 SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma Research funded by EVAg, Published by EVAg end-user
Jan 2021 SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring Science of The Total Environment Research funded by EVAg, Published by EVAg partner
Aug 2020 SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February–March 2020 Emerging Infectious Diseases Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Apr 2021 SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus Viruses Research funded by EVAg, Published by EVAg partner
Jun 2021 SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19 PLoS ONE Research funded by EVAg, Published by EVAg end-user
Nov 2017 Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection Journal of Virology Research funded by EVAg, Published by EVAg partner
May 2020 Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies Emerging Infectious Diseases Research funded by EVAg, Published by EVAg partner
Dec 2017 Serological association between Leishmania infantum and sand fly fever Sicilian (but not Toscana) virus in sheltered dogs from southern Portugal Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Feb 2019 Serological evidence of infection with dengue and Zika viruses in horses on French Pacific Islands PLoS Neglected Tropical Diseases Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Oct 2016 Seroprevalence of Sandfly‐Borne Phleboviruses Belonging to Three Serocomplexes (Sandfly fever Naples, Sandfly fever Sicilian and Salehabad) in Dogs from Greece and Cyprus Using Neutralization Test PLoS Neglected Tropical Diseases Research funded by EVAg, Published by EVAg partner
Jul 2021 Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned Clinical Microbiology and Infection Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Jan 2021 Seroprevalence of Toscana Virus and Sandfly Fever Sicilian Virus in European Bat Colonies Measured Using a Neutralization Test Viruses Research funded by EVAg, Published by EVAg partner
Dec 2016 Seroprevalence of Toscana virus in dogs from Corsica, France Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Jul 2020 Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients Emerging Infectious Diseases Research funded by EVAg, Published by EVAg partner
Feb 2020 Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group Research funded by EVAg, Published by EVAg partner
Jul 2020 Shortlisting SARS‐CoV‐2 Peptides for Targeted Studies from Experimental Data‐Dependent Acquisition Tandem Mass Spectrometry Data PROTEOMICS Research funded by EVAg, Published by EVAg end-user
Jan 2020 Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines Emerging Microbes & Infections Research funded by EVAg, Published by EVAg end-user
Dec 2016 Simple reverse genetics systems for Asian and African Zika viruses Scientific Reports Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Jan 2020 Sloths host Anhanga virus‐related phleboviruses across large distances in time and space Transboundary and Emerging Diseases Research funded by EVAg, Published by EVAg partner
Dec 2020 Small Interfering RNAs Are Highly Effective Inhibitors of Crimean-Congo Hemorrhagic Fever Virus Replication In Vitro Molecules Research funded by EVAg, Published by EVAg end-user
Jan 2018 Stress-induced unfolded protein response contributes to Zika virus–associated microcephaly Nature Neuroscience Research funded by EVAg, Published by EVAg end-user
Jul 2019 Structural basis for catalysis and substrate specificity of a 3C-like cysteine protease from a mosquito mesonivirus Virology Research funded by EVAg, Published by EVAg partner
Feb 2016 Structural characterization of the N-terminal part of the MERS-CoV nucleocapsid by X-ray diffraction and small-angle X-ray scattering Acta Crystallographica Section D Structural Biology Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Mar 2023 Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial eClinicalMedicine Research funded by EVAg, Published by EVAg end-user
Apr 2017 Substrate selectivity of Dengue and Zika virus NS5 polymerase towards 2′-modified nucleotide analogues Antiviral Research Research funded by EVAg, Published by EVAg partner
Mar 2018 SuPReMe: a rapid reverse genetics method to generate clonal populations of recombinant RNA viruses Emerging Microbes & Infections Research funded by EVAg, Published by EVAg partner
Dec 2020 Syncytia formation by SARS‐CoV‐2‐infected cells The EMBO Journal Research funded by EVAg, Published by EVAg partner
Jan 2019 Taxonomy of Viruses Reference Module in Biomedical Sciences Research funded by EVAg, Published by EVAg partner
Feb 2021 Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus Viruses Research funded by EVAg, Published by EVAg partner
Apr 2016 The 3.8 A resolution cryo-EM structure of Zika virus Science Research funded by EVAg, Published by EVAg end-user
Aug 1996 The 5'-terminal region of a tombusvirus genome determines the origin of multivesicular bodies Journal of General Virology Research funded by EVAg, Published by EVAg end-user

Pages